Published in Rev Infect Dis on June 25, 1985
Management of cerebral infection. J Neurol Neurosurg Psychiatry (1993) 0.86
Brain Abscess, Subdural Empyema, and Intracranial Epidural Abscess. Curr Infect Dis Rep (1999) 0.81
Nonsurgical treatment of a traumatic brain abscess in a child. Childs Nerv Syst (1986) 0.78
Chemotherapy for bacterial infections of the central nervous system. West J Med (1987) 0.75
Brain abscess in the computed tomography era: A 10-year experience from Auckland, New Zealand. Can J Infect Dis (1993) 0.75
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med (1997) 5.88
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med (1992) 5.84
T cell response to Mycobacterium tuberculosis. J Infect Dis (1993) 5.53
Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 4.25
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science (1988) 3.44
Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol (2001) 3.06
Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis (2006) 2.83
Inhibition of B lymphocyte activation by interferon-gamma. J Immunol (1987) 2.80
Serious infections from Bacillus sp. JAMA (1979) 2.67
Human immune response to Mycobacterium tuberculosis antigens. Infect Immun (1991) 2.39
In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus. Antimicrob Agents Chemother (1978) 2.21
Teichoic acid serologic diagnosis of staphylococcal endocarditis. Use of gel diffusion and counterimmunoelectrophoretic methods. Ann Intern Med (1975) 2.15
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 2.14
Microbiologic study of street heroin and injection paraphernalia. J Infect Dis (1974) 2.10
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med (1987) 2.05
Heterogeneity of helper/inducer T lymphocytes. III. Responses of IL-2- and IL-4-producing (Th1 and Th2) clones to antigens presented by different accessory cells. J Immunol (1990) 1.89
Staphylococcus aureus bacteremia: relationship between formation of antibodies to teichoic acid and development of metastatic abscesses. J Infect Dis (1978) 1.88
A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol (2006) 1.86
Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell Immunol (2000) 1.84
Staphylococcal endocarditis in drug users. Clinical and microbiologic aspects. Arch Intern Med (1975) 1.83
An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol (1991) 1.80
Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun (1996) 1.77
Bacillus cereus panophthalmitis: source of the organism. Rev Infect Dis (1982) 1.74
New cause for false-positive results with the cryptococcal antigen test by latex agglutination. J Clin Microbiol (1985) 1.70
Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention. Int J Tuberc Lung Dis (2007) 1.69
Gram-positive pneumonias. Med Clin North Am (1980) 1.64
In vivo and in vitro characterization of murine T-cell clones reactive to Mycobacterium tuberculosis. Infect Immun (1987) 1.63
CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. J Immunol (1995) 1.62
Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis. J Clin Invest (1991) 1.60
Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J Immunol (1993) 1.57
Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy. Am J Trop Med Hyg (1987) 1.56
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med (2000) 1.55
Neutrophil-mediated mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice. Infect Immun (2002) 1.52
CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol (2001) 1.51
Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J Immunol (1997) 1.50
Teichoic acid antibodies in the diagnosis of serious infections with Staphylococcus aureus. Ann Intern Med (1976) 1.49
Clinical and microbiologic aspects of serious infections caused by Staphylococcus epidermidis. Scand J Infect Dis (1983) 1.39
Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J Immunol (1999) 1.34
Detection of endotoxin in cerebrospinal and joint fluids by limulus assay. Arch Intern Med (1977) 1.33
Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci. Antimicrob Agents Chemother (1984) 1.28
Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect Immun (2001) 1.27
Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation. J Immunol (2001) 1.26
Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis (1974) 1.24
Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation. Immunology (1994) 1.19
Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy. J Clin Microbiol (2009) 1.18
Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults. J Infect Dis (1977) 1.16
Neutropenia probably resulting from nafcillin. JAMA (1975) 1.15
Tuberculous liver abscess. Tubercle (1984) 1.15
Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review. Rev Infect Dis (1990) 1.14
Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures. Tuberculosis (Edinb) (2011) 1.13
Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra. J Infect Dis (1998) 1.11
Evidence for the secretion of soluble peptidoglycans by clinical isolates of Staphylococcus aureus. Infect Immun (1982) 1.11
Vancomycin-associated thrombocytopenia: case report and review of the literature. Am J Hematol (1999) 1.11
In vitro correlation of platelet aggregation with occurrence of disseminated intravascular coagulation and subacute bacterial endocarditis. J Lab Clin Med (1987) 1.10
Antibiotic susceptibility and synergy of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother (1982) 1.10
Human immunodeficiency virus (HIV) infection in older people: a case report. J Am Geriatr Soc (1998) 1.09
Staphylococcal septicemia and disseminated intravascular coagulation. Staphylococcus aureus endocarditis mimicking meningococcemia. Arch Intern Med (1977) 1.09
Antibody levels to bacterial peptidoglycan in human sera during the time course of endocarditis and bacteremic infections caused by Staphylococcus aureus. Infect Immun (1981) 1.09
Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infections. Arch Intern Med (1978) 1.08
Induction of murine T-helper-cell responses to the filarial nematode Brugia malayi. Infect Immun (1993) 1.08
Fascioliasis: case reports and review. Clin Infect Dis (1993) 1.08
Regulation of human CD4(+) alphabeta T-cell-receptor-positive (TCR(+)) and gammadelta TCR(+) T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta. Infect Immun (1999) 1.04
Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity. Clin Microbiol Infect (2013) 1.04
Staphylococcus aureus among insulin-injecting diabetic patients. An increased carrier rate. JAMA (1975) 1.04
Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndrome. J Infect Dis (1985) 1.04
Teichoic acids in pathogenic Staphylococcus aureus. J Clin Microbiol (1977) 1.02
Listeria monocytogenes infections in patients with AIDS: report of five cases and review. Rev Infect Dis (1991) 1.00
A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL. J Infect Dis (2011) 1.00
Brugia malayi: acquired resistance to microfilariae in BALB/c mice correlates with local Th2 responses. Exp Parasitol (1993) 1.00
Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med (1978) 1.00
Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses. Immunol Rev (1999) 0.98
Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease. J Clin Microbiol (2001) 0.98
Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine. Infect Immun (1980) 0.97
Flow analysis of MHC molecules and other membrane proteins in isolated phagosomes. J Immunol Methods (1998) 0.94
Processing of Mycobacterium tuberculosis bacilli by human monocytes for CD4+ alphabeta and gammadelta T cells: role of particulate antigen. Infect Immun (1998) 0.93
Staphlococcal endocarditis in parenteral drug abusers: source of the organism. Ann Intern Med (1975) 0.93
Skin and skin structure infections in the patient at risk: carrier state of Staphylococcus aureus. Am J Med (1984) 0.92
Relapse of staphylococcal endocarditis after clindamycin therapy. Am J Med Sci (1975) 0.92
Class II major histocompatibility complex molecule expression on murine eosinophils activated in vivo by Brugia malayi. Infect Immun (1993) 0.92
Phagocytic processing of antigens for presentation by class II major histocompatibility complex molecules. Cell Microbiol (1999) 0.91
Differential regulation of IFN-gamma, TNF-alpha, and IL-10 production by CD4(+) alphabetaTCR+ T cells and vdelta2(+) gammadelta T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra. Cell Immunol (1999) 0.91
Transmission of Giardia lamblia from a day care center to the community. Am J Public Health (1986) 0.91
Alveolar macrophages as accessory cells for human gamma delta T cells activated by Mycobacterium tuberculosis. J Immunol (1995) 0.91
Value of the ring-enhancing sign in differentiating intracerebral hematomas and brain abscesses. Arch Intern Med (1987) 0.90
Regulation of production of tumor necrosis factor alpha in monocytes stimulated by the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun (1995) 0.90
Cervical osteomyelitis. Infection due to Staphylococcus epidermidis in hemodialysis patients. JAMA (1978) 0.90
Synergism of aminoglycosides and carbenicillin against resistant strains of Serratia marcescens. J Antimicrob Chemother (1979) 0.89
Rheumatoid factor in acute bacterial endocarditis. Arthritis Rheum (1976) 0.88
Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects. J Infect Dis (2000) 0.88
Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment. Int J Tuberc Lung Dis (2013) 0.88
Disseminated Trichosporon infection. Occurrence in an immunosuppressed patient with chronic active hepatitis. Arch Intern Med (1980) 0.88
Antimicrobial activity of street heroin. J Infect Dis (1980) 0.88
Group G streptococcus. Am J Med Sci (1980) 0.87
Gram-negative meningitis associated with transsphenoidal surgery: case reports and review. Clin Infect Dis (1994) 0.87
Characterization of suppressor function of human alveolar macrophages for T lymphocyte responses to phytohemagglutinin: cellular selectivity, reversibility, and early events in T cell activation. Am J Respir Cell Mol Biol (1993) 0.87
Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression. J Clin Invest (1996) 0.87
Mucormycosis in transplant patients. Am Surg (1980) 0.87
Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda. Int J Tuberc Lung Dis (2013) 0.86